Biotech Fund Flanders
9
19M
6
0.30
0.33
2
- Stages of investment
- Areas of investment
Summary
In 1994 was created Biotech Fund Flanders, which is appeared as VC. The fund was located in Europe if to be more exact in Belgium. The leading representative office of defined VC is situated in the Antwerp.
The typical case for the fund is to invest in rounds with 7-8 participants. Despite the Biotech Fund Flanders, startups are often financed by Gimv, Sofinnova Partners, Life Sciences Partners. The meaningful sponsors for the fund in investment in the same round are Gimv, Life Sciences Partners, Sofinnova Partners. In the next rounds fund is usually obtained by Gimv, MP Healthcare Venture Management, Kempen & Co.
We can highlight the next thriving fund investment areas, such as Biopharma, E-Commerce. The fund has no specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Diatos, Pronota, Devgen. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Belgium.
This Biotech Fund Flanders works on 14 percentage points more the average amount of lead investments comparing to the other organizations. The top amount of exits for fund were in 2015. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2007.
Investments analytics
Analytics
- Total investments
- 9
- Lead investments
- 0
- Exits
- 2
- Rounds per year
- 0.30
- Follow on index
- 0.33
- Investments by industry
- Biotechnology (6)
- Pharmaceutical (3)
- Clinical Trials (2)
- Biopharma (2)
- Health Care (2) Show 5 more
- Investments by region
-
- Belgium (5)
- Togo (1)
- France (1)
- Peak activity year
- 2006
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 15
- Avg. valuation at time of investment
- 97M
- Group Appearance index
- 1.00
- Avg. company exit year
- 12
- Avg. multiplicator
- 5.43
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Virovet | 28 May 2020 | Biotechnology, Pharmaceutical, Veterinary | Early Stage Venture | 7M | Flemish Brabant, Leuven, Belgium |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.